Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, and Antiplatelet Therapy and Cardiovascular Diseases.
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction
Complex Percutaneous Coronary Intervention in Patients Unable to Undergo Coronary Artery Bypass Grafting During the COVID-19 Pandemic: Insights From the UK-ReVasc Registry
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)
Outcomes following <scp>PCI</scp> in <scp>CABG</scp> candidates during the <scp>COVID</scp>‐19 pandemic: The prospective multicentre <scp>UK‐ReVasc</scp> registry
Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease
Neoatherosclerosis in Patients With Coronary Stent Thrombosis
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial
Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium
Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
Long-Term Follow-Up of Elective Chronic Total Coronary Occlusion Angioplasty
Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction
Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?
Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A Propensity‐Matched Study